Viral vectors remain the cornerstone of modern gene therapy, enabling targeted delivery of therapeutic genes to specific tissues. As the pipeline of gene- and cell-based therapies expands, the complexity of vector engineering and manufacturing has surged. In response, artificial intelligence (AI) and machine learning (ML) are transforming the design, optimization, and scale-up of viral vectors, […]